← Leaderboards
Dae Won Park
University Of Colorado Denver
$2,699,011
Attributed
$3,105,036
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $602K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,105,036 · 5
By mechanism
R21$1,590,855 · 4
R01$1,514,181 · 1
Top collaborators
- Noah Ray Johnson2 shared
- Malik Y. Kahook2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Neera Tewari-Singh$3,731,189
- Adam J Atherly$2,282,503
- Noah Ray Johnson$2,485,755
- Daniel D Matlock$6,653,670
- Malik Y. Kahook$202,758
Others in their field
Top investigators on “Environment”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Steven E Reis · University Of Pittsburgh At Pittsburgh$247,744,348
- Everette D Joseph · Howard University$244,517,972
- Eric J Barron · Pennsylvania State Univ University Park$244,517,972
Research focus
EnvironmentIn VivoAlzheimer&AposMedicalInjurySiteAlternative TreatmentSuccessCompliance BehaviorTreatment StrategyNatural RegenerationPolymersAmericanCell DeathOptic NerveAttentionAccountingOptic Nerve DisorderCell SurvivalBlindnessAqueousNerve CrushAxon RegenerationAxonal Degeneration
Grant awards (12)
Determining the role of tissue stiffness in the development of Alzheimer's disease pathology$188,825
R21 · FY2024 · AG · contact PI
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration$384,310
R01 · FY2023 · EY · contact PI
Determining the role of tissue stiffness in the development of Alzheimer's disease pathology$217,710
R21 · FY2023 · AG · contact PI
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration$372,781
R01 · FY2022 · EY · contact PI
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration$372,780
R01 · FY2021 · EY · contact PI
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration$384,310
R01 · FY2020 · EY · contact PI
A Functional Reverse Thermal Gel for Retinal Ganglion Cell Axon Regeneration$189,129
R21 · FY2016 · EY · contact PI
A biomimetic reverse thermal gel for the treatment of myocardial infarction$188,726
R21 · FY2015 · HL · contact PI
A biomimetic reverse thermal gel for optic nerve regeneration$188,311
R21 · FY2015 · EY · contact PI
A Functional Reverse Thermal Gel for Retinal Ganglion Cell Axon Regeneration$186,050
R21 · FY2015 · EY · contact PI
A biomimetic reverse thermal gel for optic nerve regeneration$217,204
R21 · FY2014 · EY · contact PI
A biomimetic reverse thermal gel for the treatment of myocardial infarction$214,900
R21 · FY2014 · HL · contact PI